USDH Latest NewsDH NEWSLatest NewsNEWSInternational

FDA approves emergency usage of remdesivir to patients with high risk of hospitalization

On Friday, the US Food and Medicine Administration expanded its clearance for the use of an anti-viral drug, called remdesivir, which was developed by the Gilead Sciences, to include non-hospitalized children aged 12 and up with mild-to-moderate COVID-19 disease and a high risk of hospitalisation.

Veklury was formerly only used in individuals who needed to be admitted to the hospital.

shortlink

Post Your Comments


Back to top button